Project Grant K99HD115830
- Federal Grant Award Summary The University of Illinois received a $498,000 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded February 1, 2026, with completion targeted for January 31, 2029. This K99/R00 career development award supports longitudinal neurodevelopmental research examining neural markers of developmental delays in premature and full-term infants. The...
- This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $489,500 to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to conduct research on identifying early neurobiological markers and developmental factors that impact language acquisition in children with autism spectrum disorder (ASD). The research aims to (1) characterize resting state EEG differences...
- Federal Project Grant Award Summary The National Institute of Child Health and Human Development awarded a Project Grant totaling $147,037 to The Children's Hospital of Philadelphia Research Institute on July 21, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865). This award supports a longitudinal neurodevelopmental research initiative designed to identify optimal electrophysiological markers for predicting developmental outcomes in infants. The project...
- Federal Grant Award Summary The Children's Research Institute received a $500,500 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective June 1, 2025, through May 31, 2027. The award funds the development of quantitative electroencephalogram (EEG) biomarkers for Smith-Magenis Syndrome (SMS), a rare neurodevelopmental disorder caused by deletion or mutation of the...
- This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $489,500 in funding to The Children's Hospital Corporation, doing business as Boston Children's Hospital, to conduct research on early predictors of late talking and primary language impairment (PLI) in young children. The research project aims to trace longitudinal trajectories of electroencephalogram (EEG) features from 2-24 months...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $220,050 to The Children's Hospital of Philadelphia Research Institute under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) on August 1, 2025, for a five-year project concluding July 31, 2030. This Project Grant supports research to advance clinical trial readiness for SYNGAP1-related disorder (SYNGAP1-RD), a rare monogenic...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $625,859 to the University of California, Los Angeles under its Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program on January 27, 2026. This Project Grant supports research aimed at developing and validating objective, quantitative measures of infant motor function that serve as predictive biomarkers for Autism Spectrum Disorder (ASD)....
- Summary: Neurophysiological Correlates of Cognition Over Multi-Day Timescales in Epilepsy The National Institute of Neurological Disorders and Stroke (NINDS) awarded Massachusetts General Hospital $234,630 on August 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to conduct a five-year prospective research study examining the neurophysiological basis of cognitive impairment in temporal lobe epilepsy (TLE). The research...
- Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Virginia a $768,909 Project Grant (CFDA 93.242 - Mental Health Research Grants) effective May 1, 2025, through January 31, 2030, to conduct mechanistic research on prefrontal cortex development during critical neonatal periods. The project, titled "Synchronous Network Activity in the Maturing Prefrontal Cortex: Mechanistic Impact of Birth Timing and Serotonin," will investigate how premature...
- Grant Award Summary The University of Virginia received a $630,861 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded August 11, 2025, with a completion date of July 31, 2030. This research initiative will develop a novel physiologic biomarker (physiomarker) for early cerebral palsy (CP) risk detection by analyzing continuous vital sign and waveform data...
NEURAL MARKERS OF DEVELOPMENTAL DELAYS IN PREMATURE AND FULL TERM INFANTS - PROJECT SUMMARY/ABSTRACT PREMATURE INFANTS ARE VULNERABLE TO LONG-TERM SOCIAL, COGNITIVE, AND BEHAVIORAL DIFFICULTIES. HOWEVER, NOT ALL PREMATURE INFANTS GO ON TO HAVE DEVELOPMENTAL DELAYS. MODERATE TO LATE PRETERM INFANTS (BORN AFTER 32 WEEKS) REPRESENT A MISSED CLINICAL POPULATION AS THEY DO NOT AUTOMATICALLY QUALIFY FOR FEDERALLY PROVIDED HEALTH SCREENING AND INTERVENTION PROGRAMS. THEREFORE, THE INVESTIGATION INTO THE NEURAL MECHANISMS UNDERLYING HETEROGENEITIES IN BEHAVIORAL DEVELOPMENT IS A PROMISING APPROACH TO IMPROVE OUR ABILITY TO IDENTIFY INFANTS IN NEED OF ADDITIONAL SERVICES AND INFORM TREATMENT RESPONSES. THIS IS ALSO AN IMPORTANT PUBLIC HEALTH MISSION AND A NICHD FUNDING PRIORITY. THE PROPOSED K99 STUDY WILL CHART BRAIN DEVELOPMENT USING ELECTROENCEPHALOGRAPHY (EEG) DURING WELL-BABY VISITS (4, 9, AND 12 MONTHS) AT A PRIMARY CARE CLINIC AND A FOLLOW-UP LAB VISIT (24 MONTHS). PARTICIPANTS (N = 720 TARGET RECRUITMENT) WILL BE DRAWN FROM AN ONGOING R01 (PI NELSON: 5R01NS120986) STUDY THAT EXAMINES IF EEG IS FEASIBLE IN THE CONTEXT OF A PRIMARY CARE FACILITY AND AIDS IN THE EARLY IDENTIFICATION OF CHILDREN WHO GO ON TO RECEIVE AN AUTISM DIAGNOSIS. TO THIS END, I WILL ASSESS THE LONGITUDINAL TRAJECTORIES OF BRAIN DEVELOPMENT IN PRETERM AND FULL TERM INFANTS ACROSS THE FIRST TWO YEARS OF LIFE (AIM 1). NEXT, I WILL DETERMINE THE LINK BETWEEN BRAIN DEVELOPMENT AND DEVELOPMENT DELAYS (AIM 2). FINALLY, IN THE R00 PHASE, I WILL RECRUIT AND LONGITUDINALLY FOLLOW A NEW SAMPLE OF PRETERM (1 MONTH CHRONOLOGICAL, 1 MONTH CORRECTED, 4 MONTHS CHRONOLOGICAL, AND 4 MONTHS CORRECTED) AND FULL TERM INFANTS (1 MONTH CHRONOLOGICAL AND 4 MONTHS CHRONOLOGICAL). USING A MULTIMETHOD NEUROIMAGING APPROACH (SIMULTANEOUS FUNCTIONAL NEAR- INFRARED SPECTROSCOPY AND EEG) I WILL EXPLORE WHEN DISRUPTIONS IN CEREBRAL BLOOD FLOW RESPONSES AND BRAIN ACTIVITY FIRST EMERGE AND THEIR ASSOCIATIONS WITH DEVELOPMENTAL DELAY. OVERALL, UNDERSTANDING NEURODEVELOPMENTAL PROCESSES BEFORE AND WHEN DELAYS FIRST EMERGE PROVIDES A TRACTABLE APPROACH TO IMPROVING PSYCHOLOGICAL OUTCOMES AND WELL-BEING ACROSS THE LIFESPAN. THE TRAINING AND EXPERIENCE GAINED DURING THE AWARD PERIOD WILL SUPPORT MY TRANSITION TO BECOMING AN INDEPENDENT INVESTIGATOR AND WILL CONTRIBUTE TO MY LONG-TERM RESEARCH GOALS OF INVESTIGATING INFANT BRAIN MECHANISMS UNDERLYING HETEROGENEITIES IN SOCIAL AND COGNITIVE DEVELOPMENT.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 1/28/26 | ||
| Not listed | $132.7k | 5/6/25 | ||
| Not listed | $132.7k | 5/6/25 | ||
| Not listed | $132.7k | 7/26/24 | ||
| Not listed | $132.7k | 7/26/24 |